×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| GENNEX LABORATORIES LTD. | 400.06 | 50.65 | 377.07 | 0.22 | 321.0 | 17.2 |
| OXYGENTA PHARMACEUTICAL LIMITE | 336.94 | -39.28 | 332.06 | 1.12 | 299 | |
| CORAL LABORATORIES LTD. | 255.09 | 61.44 | 229.86 | 17.20 | 278 | 10.2 |
Gennex Laboratories Ltd, with Security Code 531739, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 13.9 | 19.1 | 13.8 | 18.1 | 14.1 | 14.2 | 17.0 | 21.3 | 21.3 | 24.6 |
| Expenses | 13.1 | 17.8 | 12.8 | 16.9 | 10.2 | 10.3 | 15.6 | 18.2 | 18.4 | 21.0 |
| Operating Profit | 0.9 | 1.3 | 1.1 | 1.3 | 3.9 | 4.0 | 1.4 | 3.1 | 2.9 | 3.7 |
| OPM % | 6.29% | 7.02% | 7.86% | 7.01% | 27.69% | 27.88% | 8.41% | 14.51% | 13.71% | 15.01% |
| Other Income | 0.6 | 0.5 | 0.7 | 1.6 | 0.0 | 0.1 | 2.2 | 2.0 | 2.5 | 1.8 |
| Interest | 0.3 | 0.4 | 0.2 | 0.5 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.5 |
| Depreciation | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 |
| Profit before tax | 1.0 | 1.4 | 1.4 | 2.2 | 3.4 | 3.5 | 3.2 | 4.6 | 4.9 | 5.0 |
| Tax % | 25.1% | 25.2% | 25.2% | 22.3% | 25.3% | 25% | 16.5% | 14.7% | 15.3% | 17% |
| Net Profit | 0.8 | 1.0 | 1.1 | 1.7 | 2.6 | 2.7 | 2.6 | 3.9 | 4.2 | 4.2 |
| EPS in Rs | 0.06 | 0.08 | 0.07 | 0.1 | 0.15 | 0.15 | 0.15 | 0.22 | 0.18 | 0.18 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 19.1 | 13.9 | 18.7 | 16.5 | 17.6 | 19.1 | 33.5 | 28.3 | 31.5 | 37.7 |
| Expenses | 17.8 | 12.8 | 17.3 | 11.4 | 12.4 | 16.6 | 29.3 | 24.1 | 25.9 | 32.9 |
| Operating Profit | 1.3 | 1.1 | 1.4 | 5.1 | 5.2 | 2.5 | 4.2 | 4.2 | 5.6 | 4.9 |
| OPM % | 7% | 7.9% | 7.4% | 30.7% | 29.4% | 13.3% | 12.7% | 14.9% | 17.8% | 12.9% |
| Other Income | 0.5 | 0.7 | 2.1 | 0.0 | 0.6 | 2.3 | 2.0 | 2.5 | 1.8 | 2.3 |
| Interest | 0.4 | 0.2 | 0.6 | 0.7 | 0.8 | 0.8 | 0.7 | 0.7 | 1.1 | 0.8 |
| Depreciation | 0.1 | 0.2 | 0.4 | 0.6 | 1.0 | 0.5 | 0.2 | 0.5 | 0.2 | 0.5 |
| Profit before tax | 1.4 | 1.5 | 2.5 | 3.7 | 3.9 | 3.5 | 5.3 | 5.5 | 6.1 | 5.8 |
| Tax % | 25.2% | 25.2% | 19.1% | 23.4% | 22.4% | 21.4% | 15.2% | 15.4% | 12.3% | 12.9% |
| Net Profit | 1.0 | 1.1 | 2.0 | 2.9 | 3.1 | 2.8 | 4.5 | 4.7 | 5.4 | 5.1 |
| EPS in Rs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 4% |
| 3 Years: | 4% |
| TTM: | 47% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 50% |
| 5 Years: | 40% |
| 3 Years: | 40% |
| TTM: | 73% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 45% |
| 3 Years: | 23% |
| 1 Year: | -33% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 9% |
| 3 Years: | 13% |
| TTM: | 82% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 42% |
| 3 Years: | 43% |
| TTM: | 77% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 45% |
| 3 Years: | 23% |
| 1 Year: | -33% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|